IBEX (NASDAQ:IBEX) CEO Robert Thomas Dechant Sells 5,000 Shares of Company Stock

IBEX Limited (NASDAQ:IBEX) CEO Robert Dechant sold 5,000 shares of the business’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $50.01, for a total value of $250,050.00. Following the completion of the sale, the chief executive officer directly owned 297,448 shares in the company, valued at approximately $14,875,374.48. This represents a 1.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Robert Thomas Dechant also recently made the following trade(s):

• On Friday, September 25th, Robert Dechant sold 5,000 shares of IBEX stock. The stock was sold at an average price of $45.02, for a total value of $225,100.00.
• On Tuesday, September 15th, Robert Dechant sold 25,000 shares of IBEX stock. The shares were sold at an average price of $39.99, for a total value of $999,750.00.

IBEX Stock Performance

Shares of NASDAQ IBEX opened at $52.23 on Wednesday. IBEX Limited has a 52-week low of $25.94 and a 52-week high of $52.29. The business has a fifty day moving average of $43.52 and a two-hundred day moving average of $34.63. The stock has a market cap of $696.23 million, a PE ratio of 15.83 and a beta of 0.74.

IBEX (NASDAQ:IBEX) last posted its earnings results on Thursday, November 5th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.20. The business had revenue of $175.23 million for the quarter, compared to analyst estimates of $169.31 million. IBEX had a net margin of 7.34% and a return on equity of 29.10%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on IBEX shares. Wall Street Zen raised IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday. Royal Bank Of Canada raised their price target on IBEX from $40.00 to $45.00 and gave the company a “sector perform” rating in a report on Tuesday. Robert W. Baird raised their price target on IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a report on Monday, September 28th. Finally, Weiss Ratings upgraded IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, October 12th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $44.50.

Trending Headlines about IBEX

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Ieq Capital LLC boosted its stake in shares of IBEX by 11.8% in the 3rd quarter. Ieq Capital LLC now owns 14,638 shares of the company’s stock valued at $633,000 after purchasing an additional 1,545 shares during the last quarter. Boston Partners grew its holdings in shares of IBEX by 15.3% in the 3rd quarter. Boston Partners now owns 397,353 shares of the company’s stock valued at $17,189,000 after buying an additional 52,638 shares during the period. Virtus Advisers LLC increased its holdings in shares of IBEX by 18.9% in the third quarter. Virtus Advisers LLC now owns 22,920 shares of the company’s stock worth $992,000 after acquiring an additional 3,645 shares in the last quarter. Russell Investments Group Ltd. increased its stake in IBEX by 370.5% during the 3rd quarter. Russell Investments Group Ltd. now owns 14,361 shares of the company’s stock worth $623,000 after purchasing an additional 11,309 shares in the last quarter. Finally, Ritholtz Wealth Management increased its position in shares of IBEX by 10.0% during the third quarter. Ritholtz Wealth Management now owns 60,230 shares of the company’s stock worth $2,606,000 after acquiring an additional 5,480 shares in the last quarter. Institutional investors and hedge funds own 81.24% of the company’s stock.

IBEX Company Profile

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.